IKT - Inhibikase Therapeutics GAAP EPS of -$0.16 misses by $0.01 revenue of $0.6M May, 15 2023 12:00 PM Inhibikase Therapeutics Inc. 2023-05-15 12:00:54 ET Inhibikase Therapeutics press release ( NASDAQ: IKT ): Q1 GAAP EPS of -$0.16 misses by $0.01 . Revenue of $0.6M (+1100.0% Y/Y). For further details see: Inhibikase Therapeutics GAAP EPS of -$0.16 misses by $0.01, revenue of $0.6M